BlackRock, Inc.

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 2012383 New York, NY

Position in BCRX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$238,930,360

+$23,292,961 QoQ

Shares Held

23,893,036

+5.5% QoQ

Ownership

9.35%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 316 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 96% Shared 0% None 4%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $21,635,633,053 across 65 Drug Manufacturers - Specialty & Generic names. BCRX ranks #16 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	5,294,529	$2,868,734,637
2	ZTS	Zoetis Inc.	39,430,181	$2,833,452,797
3	NBIX	Neurocrine Biosciences Inc	13,711,607	$2,310,954,234
4	TEVA	Teva Pharmaceutical Industries Ltd	63,894,301	$2,164,738,910
5	ALKS	Alkermes plc.	29,235,739	$1,531,952,715
6	VTRS	Viatris Inc	86,019,468	$1,365,989,144
7	ELAN	Elanco Animal Health Inc	48,849,973	$1,202,197,829
8	HIMS	Hims & Hers Health, Inc.	28,703,514	$995,150,823

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$238,930,360	23,893,036	+5.5%	Shares	Sole	2026-08-07
2026-03-31	$215,637,399	22,650,988	+7.2%	Shares	Sole	2026-05-13
2025-12-31	$164,874,764	21,137,791	-0.5%	Shares	Sole	2026-02-12
2025-09-30	$161,256,190	21,245,876	-0.8%	Shares	Sole	2025-11-12
2025-06-30	$191,975,600	21,425,849	-5.9%	Shares	Sole	2025-08-12
2025-03-31	$170,769,341	22,769,246	+3.1%	Shares	Sole	2025-05-02
2024-12-31	$166,155,619	22,095,163	+5.6%	Shares	Sole	2025-02-07
2024-09-30	$158,961,374	20,915,971	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.